119 related articles for article (PubMed ID: 16392183)
21. Prognostic significance of DNA ploidy in oral squamous cell carcinomas. A retrospective flow and image cytometric study with comparison of DNA ploidy in excisional biopsy specimens and resection specimens, primary, tumors, and lymph node metastases.
Baretton G; Li X; Stoll C; Fischer-Brandies E; Schmidt M; Löhrs U
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jan; 79(1):68-76. PubMed ID: 7614165
[TBL] [Abstract][Full Text] [Related]
22. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
23. Ploidy levels in nonneoplastic and neoplastic thyroid cells.
Auer GU; Bäckdahl M; Forsslund GM; Askensten UG
Anal Quant Cytol Histol; 1985 Jun; 7(2):97-106. PubMed ID: 4026949
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of image cytometric assessments of nuclear DNA distribution pattern of neoplastic cells in thyroid medullary carcinoma. A retrospective study using disaggregated, formalin-fixed, paraffin-embedded specimens.
Soares J; Fonseca I; Limbert E; Falkmer UG; Falkmer S
APMIS; 1991 Aug; 99(8):745-54. PubMed ID: 1859647
[TBL] [Abstract][Full Text] [Related]
26. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.
Ke Z; Liu Y; Zhang Y; Li J; Kuang M; Peng S; Liang J; Yu S; Su L; Chen L; Sun C; Li B; Cao J; Lv W; Xiao H
Oncol Rep; 2018 Aug; 40(2):659-668. PubMed ID: 29901149
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of primary and metastatic squamous cell carcinomas of the oral and maxillofacial region.
Suzuki K; Chen RB; Nomura T; Nakajima T
J Oral Maxillofac Surg; 1994 Aug; 52(8):855-61; discussion 861-2. PubMed ID: 8040741
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary.
Bakshi N; Rajwanshi A; Patel F; Ganguly NK
Anal Quant Cytol Histol; 1998 Jun; 20(3):215-20. PubMed ID: 9642449
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
31. Cellular DNA pattern, S-phase frequency and survival in papillary thyroid cancer.
Hrafnkelsson J; Stål O; Eneström S; Jonasson JG; Björnsson J; Olafsdottir K; Nordenskjöld B
Acta Oncol; 1988; 27(4):329-33. PubMed ID: 3202993
[TBL] [Abstract][Full Text] [Related]
32. Is agNOR and DNA ploidy analysis useful for evaluating thyroid neoplasms?
Camargo RS; Maeda MY; di Loreto C; Shirata NK; Anselmo Garcia E; Filho AL
Anal Quant Cytol Histol; 2005 Jun; 27(3):157-61. PubMed ID: 16121637
[TBL] [Abstract][Full Text] [Related]
33. [Flow cytometric DNA content analysis in thyroid carcinoma].
Zuo LF
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid.
Bronner MP; Clevenger CV; Edmonds PR; Lowell DM; McFarland MM; LiVolsi VA
Am J Clin Pathol; 1988 Jun; 89(6):764-9. PubMed ID: 3369368
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
36. Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern.
Castro P; Sansonetty F; Soares P; Dias A; Sobrinho-Simões M
Virchows Arch; 2001 Apr; 438(4):336-42. PubMed ID: 11355166
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric measurements of nuclear DNA and ploidy analysis in Hürthle cell neoplasms of the thyroid.
McLeod MK; Thompson NW; Hudson JL; Gaglio JA; Lloyd RV; Harness JK; Nishiyama R; Cheung PS
Arch Surg; 1988 Jul; 123(7):849-54. PubMed ID: 3382350
[TBL] [Abstract][Full Text] [Related]
38. Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from disease.
Sturgis CD; Caraway NP; Johnston DA; Sherman SI; Kidd L; Katz RL
Cancer; 1999 Jun; 87(3):155-60. PubMed ID: 10385447
[TBL] [Abstract][Full Text] [Related]
39. Nuclear protein content and Ki-67 immunoreactivity in nonneoplastic and neoplastic thyroid cells.
Wallin G; Bäckdahl M; Christensson B; Grimelius L; Auer G
Anal Quant Cytol Histol; 1992 Aug; 14(4):296-303. PubMed ID: 1388566
[TBL] [Abstract][Full Text] [Related]
40. Comparison of nuclear DNA content in locally invasive and noninvasive papillary carcinoma of the thyroid gland.
Stern Y; Lisnyansky I; Shpitzer T; Nativ O; Medalia O; Feinmesser R; Aronson M
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):501-3. PubMed ID: 9374174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
